Promoters recognized by Escherichia coli RNA polymerase selected by function: highly efficient promoters from bacteriophage T5.

PubWeight™: 1.97‹?› | Rank: Top 2%

🔗 View Article (PMC 214212)

Published in J Bacteriol on October 01, 1985

Authors

R Gentz, H Bujard

Articles citing this

Bacteriophage T4 genome. Microbiol Mol Biol Rev (2003) 5.20

Promoters of Escherichia coli: a hierarchy of in vivo strength indicates alternate structures. EMBO J (1986) 3.89

Functional dissection of Escherichia coli promoters: information in the transcribed region is involved in late steps of the overall process. EMBO J (1986) 3.33

Pseudomonas aeruginosa infection in cystic fibrosis: nucleotide sequence and transcriptional regulation of the algD gene. Nucleic Acids Res (1987) 2.63

Training back-propagation neural networks to define and detect DNA-binding sites. Nucleic Acids Res (1991) 2.47

lac Repressor blocks transcribing RNA polymerase and terminates transcription. Proc Natl Acad Sci U S A (1986) 2.07

Identification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus. Infect Immun (2001) 1.58

Cloning and nucleotide sequence of a heat-stable enterotoxin gene from Vibrio cholerae non-O1 isolated from a patient with traveler's diarrhea. Infect Immun (1990) 1.53

Enhanced bacterial protein expression during auto-induction obtained by alteration of lac repressor dosage and medium composition. Biotechnol Prog (2007) 1.51

An assessment of neural network and statistical approaches for prediction of E. coli promoter sites. Nucleic Acids Res (1992) 1.21

Staphylococcus aureus TargetArray: comprehensive differential essential gene expression as a mechanistic tool to profile antibacterials. Antimicrob Agents Chemother (2010) 1.08

Transcription of the celE gene in Thermomonospora fusca. J Bacteriol (1988) 1.08

Transcription inhibition by the depsipeptide antibiotic salinamide A. Elife (2014) 1.06

Association of degradation and secretion of three chimeric polypeptides in Escherichia coli. J Bacteriol (1988) 1.03

How selection affects phenotypic fluctuation. Mol Syst Biol (2009) 0.98

Cloning, sequencing, and recombinational analysis with bacteriophage BF23 of the bacteriophage T5 oad gene encoding the receptor-binding protein. J Bacteriol (1991) 0.91

Insights into bacteriophage T5 structure from analysis of its morphogenesis genes and protein components. J Virol (2013) 0.91

Application of a new method of pattern recognition in DNA sequence analysis: a study of E. coli promoters. Nucleic Acids Res (1990) 0.91

Nucleotide sequence and transcription of the right early region of bacteriophage PRD1. J Bacteriol (1990) 0.90

An unstructured mRNA region and a 5' hairpin represent important elements of the E. coli translation initiation signal determined by using the bacteriophage T7 gene 1 translation start site. Nucleic Acids Res (1993) 0.87

More than 150 nucleotides flanking the initiation codon contribute to the efficiency of the ribosomal binding site from bacteriophage T7 gene 1. Nucleic Acids Res (1987) 0.86

Cloning, sequencing, and expression of bacteriophage BF23 late genes 24 and 25 encoding tail proteins. J Bacteriol (1994) 0.76

Escherichia coli promoter -10 and -35 region homologies correlate with binding and isomerization kinetics. Biochem J (1988) 0.75

Bacteriophage T5 gene D10 encodes a branch-migration protein. Sci Rep (2016) 0.75

Pseudosecretion of Escherichia coli chloramphenicol acetyltransferase by Bacillus subtilis. J Bacteriol (1987) 0.75

Strain engineering and process optimization for enhancing the production of a thermostable steryl glucosidase in Escherichia coli. J Ind Microbiol Biotechnol (2016) 0.75

Metabolic engineering of Escherichia coli W3110 for the production of L-methionine. J Ind Microbiol Biotechnol (2016) 0.75

Articles cited by this

Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08

Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68

A new method for sequencing DNA. Proc Natl Acad Sci U S A (1977) 250.51

A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res (1979) 214.95

Supercoiled circular DNA-protein complex in Escherichia coli: purification and induced conversion to an opern circular DNA form. Proc Natl Acad Sci U S A (1969) 71.62

A membrane-filter technique for the detection of complementary DNA. Biochem Biophys Res Commun (1966) 71.25

Regulatory sequences involved in the promotion and termination of RNA transcription. Annu Rev Genet (1979) 54.83

A dye-buoyant-density method for the detection and isolation of closed circular duplex DNA: the closed circular DNA in HeLa cells. Proc Natl Acad Sci U S A (1967) 48.10

Compilation and analysis of Escherichia coli promoter DNA sequences. Nucleic Acids Res (1983) 38.72

Transformation and preservation of competent bacterial cells by freezing. Methods Enzymol (1979) 7.33

Formation of an RNA primer for initiation of replication of ColE1 DNA by ribonuclease H. Proc Natl Acad Sci U S A (1980) 6.04

A novel in vitro transcription-translation system: accurate and efficient synthesis of single proteins from cloned DNA sequences. EMBO J (1984) 4.50

Transcription from efficient promoters can interfere with plasmid replication and diminish expression of plasmid specified genes. EMBO J (1982) 4.26

Cloning and analysis of strong promoters is made possible by the downstream placement of a RNA termination signal. Proc Natl Acad Sci U S A (1981) 3.77

The amino-terminal region of an imported mitochondrial precursor polypeptide can direct cytoplasmic dihydrofolate reductase into the mitochondrial matrix. EMBO J (1984) 3.69

Physical mapping of the HindIII, EcoRI, Sal and Sma restriction endonuclease cleavage fragments from bacteriophage T5 DNA. Mol Gen Genet (1976) 3.66

First-step-transfer deoxyribonucleic acid of bacteriophage T5. Bacteriol Rev (1968) 3.52

Interaction of Escherichia coli RNA polymerase with promoters of several coliphage and plasmid DNAs. Proc Natl Acad Sci U S A (1979) 2.58

The T-odd bacteriophages. CRC Crit Rev Microbiol (1975) 2.55

Electron microscopic analysis of in vitro transcriptional complexes: mapping of promoters of the coliphage T5 genome. Mol Gen Genet (1978) 2.03

Synthesis of a model promoter for gene expression in Escherichia coli. Nucleic Acids Symp Ser (1980) 1.50

Interaction of E. coli RNA polymerase with promotors of coliphage T5: the rates of complex formation and decay and their correlation with in vitro and in vivo transcriptional activity. Mol Gen Genet (1977) 1.35

Articles by these authors

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A (1992) 35.45

Transcriptional activation by tetracyclines in mammalian cells. Science (1995) 13.90

Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Res (1997) 13.15

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex. Cell (1996) 12.07

Isolation of large molecular weight DNA from agarose gels for further digestion by restriction enzymes. FEBS Lett (1975) 9.87

Organization of transcriptional signals in plasmids pBR322 and pACYC184. Proc Natl Acad Sci U S A (1981) 8.77

Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol (1994) 7.40

The receptor for the cytotoxic ligand TRAIL. Science (1997) 6.39

An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science (1997) 6.10

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science (1999) 5.99

Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A (2000) 5.99

Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci U S A (1996) 5.93

Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci U S A (1994) 5.71

Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell (1993) 5.37

Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell (1990) 4.58

A novel in vitro transcription-translation system: accurate and efficient synthesis of single proteins from cloned DNA sequences. EMBO J (1984) 4.50

Transcription from efficient promoters can interfere with plasmid replication and diminish expression of plasmid specified genes. EMBO J (1982) 4.26

A T5 promoter-based transcription-translation system for the analysis of proteins in vitro and in vivo. Methods Enzymol (1987) 4.21

Promoters largely determine the efficiency of repressor action. Proc Natl Acad Sci U S A (1988) 4.18

Promoters of Escherichia coli: a hierarchy of in vivo strength indicates alternate structures. EMBO J (1986) 3.89

Cloning and analysis of strong promoters is made possible by the downstream placement of a RNA termination signal. Proc Natl Acad Sci U S A (1981) 3.77

Regulated expression of foreign genes in mammalian cells under the control of coliphage T3 RNA polymerase and lac repressor. Proc Natl Acad Sci U S A (1989) 3.70

Physical mapping of the HindIII, EcoRI, Sal and Sma restriction endonuclease cleavage fragments from bacteriophage T5 DNA. Mol Gen Genet (1976) 3.66

Physical interaction between heat shock proteins DnaK, DnaJ, and GrpE and the bacterial heat shock transcription factor sigma 32. Cell (1992) 3.46

Functional dissection of Escherichia coli promoters: information in the transcribed region is involved in late steps of the overall process. EMBO J (1986) 3.33

Expression and purification of the leucine zipper and DNA-binding domains of Fos and Jun: both Fos and Jun contact DNA directly. Proc Natl Acad Sci U S A (1990) 3.31

Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res (1995) 3.24

Electron microscopy of size and shape of viral DNA in solutions of different ionic strengths. J Mol Biol (1967) 3.16

Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice. Nat Biotechnol (1999) 3.04

Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res (1997) 2.90

Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science (1996) 2.87

Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements. Trends Biochem Sci (1993) 2.80

A chimeric transactivator allows tetracycline-responsive gene expression in whole plants. Plant J (1994) 2.73

Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances. Methods Enzymol (2000) 2.72

Plasmids controlling synthesis of hemolysin in Escherichia coli: molecular properties. J Bacteriol (1974) 2.71

RNA polymerase II transcription blocked by Escherichia coli lac repressor. Science (1990) 2.65

Interaction of Escherichia coli RNA polymerase with promoters of several coliphage and plasmid DNAs. Proc Natl Acad Sci U S A (1979) 2.58

A cycle of binding and release of the DnaK, DnaJ and GrpE chaperones regulates activity of the Escherichia coli heat shock transcription factor sigma32. EMBO J (1996) 2.55

Electron microscopy of single-stranded DNA. J Mol Biol (1970) 2.42

The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: transcription factor AP-1 is comprised of multiple protein complexes. Genes Dev (1989) 2.41

An electron microscopic method for studying nucleic acid-protein complexes. Visualization of RNA polymerase bound to the DNA of bacteriophages T7 and T3. Biopolymers (1974) 2.24

Tightly regulated and inducible expression of dominant interfering dynamin mutant in stably transformed HeLa cells. Methods Enzymol (1995) 2.19

A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J Gene Med (2000) 2.18

Isolation and characterization of human orthologs of yeast CCR4-NOT complex subunits. Nucleic Acids Res (2000) 2.13

lac Repressor blocks transcribing RNA polymerase and terminates transcription. Proc Natl Acad Sci U S A (1986) 2.07

Promoter recognition and promoter strength in the Escherichia coli system. EMBO J (1987) 2.07

Location of single-strand interruptions in the DNA of bacteriophage T5. Proc Natl Acad Sci U S A (1969) 2.06

Electron microscopic analysis of in vitro transcriptional complexes: mapping of promoters of the coliphage T5 genome. Mol Gen Genet (1978) 2.03

The size of the rII region of bacteriophage T4. Virology (1970) 2.02

Subregions of a conserved part of the HIV gp41 transmembrane protein are differentially recognized by antibodies of infected individuals. EMBO J (1986) 2.01

A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem (1997) 2.00

Human TNF mutants with selective activity on the p55 receptor. Nature (1993) 1.91

Structure and function of the genome of coliphage T5. 1. The physical structure of the chromosome of T5 + . Eur J Biochem (1973) 1.90

Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. J Virol (2001) 1.89

LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest (1998) 1.89

I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. J Biol Chem (1997) 1.86

High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation. Nat Med (2000) 1.82

Modulation of myosin A expression by a newly established tetracycline repressor-based inducible system in Toxoplasma gondii. Nucleic Acids Res (2001) 1.78

Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur J Immunol (1991) 1.78

Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine (1990) 1.72

Inducible gene expression systems for higher eukaryotic cells. Curr Opin Biotechnol (1994) 1.69

Polymorphism of the precursor for the major surface antigens of Plasmodium falciparum merozoites: studies at the genetic level. EMBO J (1985) 1.69

Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes. Proc Natl Acad Sci U S A (1999) 1.67

1H, 13C, and 15N NMR backbone assignments and secondary structure of human interferon-gamma. Biochemistry (1992) 1.66

Stalling of Escherichia coli RNA polymerase in the +6 to +12 region in vivo is associated with tight binding to consensus promoter elements. J Mol Biol (1994) 1.66

Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRG. Cancer Res (1997) 1.66

Thrombospondin related anonymous protein (TRAP) of Plasmodium falciparum binds specifically to sulfated glycoconjugates and to HepG2 hepatoma cells suggesting a role for this molecule in sporozoite invasion of hepatocytes. EMBO J (1993) 1.64

Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Immunology (1992) 1.63

Isolation of covalently closed circular deoxyribonucleic acid from Streptomyces coelicolor A3(2). J Bacteriol (1975) 1.63

Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity. J Biol Chem (1991) 1.57

Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived. Infect Immun (1991) 1.55

Photinus pyralis luciferase: vectors that contain a modified luc coding sequence allowing convenient transfer into other systems. Gene (1994) 1.54

Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J (1994) 1.53

Regulation of coliphage T3 and T7 RNA polymerases by the lac repressor-operator system. Gene (1989) 1.46

6xHis-Ni-NTA chromatography as a superior technique in recombinant protein expression/purification. Methods Mol Biol (1994) 1.46

Doxycycline control of prion protein transgene expression modulates prion disease in mice. Proc Natl Acad Sci U S A (1998) 1.45

Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells. FASEB J (2001) 1.42

Anhydrotetracycline, a novel effector for tetracycline controlled gene expression systems in eukaryotic cells. Nucleic Acids Res (1993) 1.40

PL of coliphage lambda: an alternative solution for an efficient promoter. EMBO J (1988) 1.38

All human genes of the uteroglobin family are localized on chromosome 11q12.2 and form a dense cluster. Ann N Y Acad Sci (2000) 1.38

Interaction of E. coli RNA polymerase with promotors of coliphage T5: the rates of complex formation and decay and their correlation with in vitro and in vivo transcriptional activity. Mol Gen Genet (1977) 1.35

Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells. Nucleic Acids Res (1999) 1.34

Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. J Immunol (1992) 1.32

Nonpolymorphic regions of p190, a protein of the Plasmodium falciparum erythrocytic stage, contain both T and B cell epitopes. J Immunol (1988) 1.31

A prospective study of the association between the human humoral immune response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections. Infect Immun (1993) 1.30

Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors. J Exp Med (1997) 1.29

VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. FASEB J (1999) 1.29

Efficacy of tetracycline-controlled gene expression is influenced by cell type: commentary. Biotechniques (1995) 1.27

Electron microscopy of DNA: determination of absolute molecular weights and linear density. Mol Gen Genet (1977) 1.27

TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. FASEB J (1998) 1.25

Context-dependent effects of upstream A-tracts. Stimulation or inhibition of Escherichia coli promoter function. J Mol Biol (1994) 1.24

Identification of mammalian cell clones exhibiting highly regulated expression from inducible promoters. Trends Genet (1995) 1.23

Dissecting the functional program of Escherichia coli promoters: the combined mode of action of Lac repressor and AraC activator. Nucleic Acids Res (2001) 1.23

Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33. Blood (1998) 1.21